| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |